Skip to main content

Advertisement

Log in

Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides

  • Published:
Pituitary Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Golden WM, Weber KB, Hernandez TL, Sherman SI, Woodmansee WW, Haugen BR (2007) Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects. J Clin Endocrinol Metab 92(1):124–130. doi:10.1210/jc.2006-0696

    Article  CAS  PubMed  Google Scholar 

  2. Tebben PJ, Atkinson JL, Scheithauer BW, Erickson D (2007) Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocr Pract 13(2):169–175. doi:10.4158/EP.13.2.169

    Article  PubMed  Google Scholar 

  3. Haugen BR (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23(6):793–800. doi:10.1016/j.beem.2009.08.003

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hulusi Atmaca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atmaca, H., Islek, I. & Sentürk, N. Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides. Pituitary 17, 492–493 (2014). https://doi.org/10.1007/s11102-013-0523-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-013-0523-z

Keywords

Navigation